← Back to headlines
Eli Lilly CEO Discusses GLP-1s' Impact on America
The CEO of Eli Lilly and Company (LLY) shares insights on how GLP-1 medications are expected to reshape various aspects of America.
23 Jun, 19:55 — 23 Jun, 19:55
Sources
Showing 1 of 1 sources



